EW: Edwards Lifesciences Inc. O‘sish sur’atiga tuzatilgan narx-foyda
Edwards Lifesciences (EW) uchun xavflar tor implantlar portfeli va tartibga soluvchi kechikishlar bilan bog'liq. Yuqori marjalar mukammal yurak klapanlari logistikasi va laboratoriyalar tarmog'i tomonidan qo'llab-quvvatlanadi. Aholining qarishi talabni kafolatlaydi, garchi muvaffaqiyat minimal invaziv usullarning joriy etilishiga bog'liq bo'lsa-da. Qiymatning o'sishga nisbati foyda ko'rsatkichlarining dinamikasini namoyish etadi, bunda oxirgi marka 2.19 darajasida turibdi.
Edwards Lifesciences (EW) kompaniyasining tahliliy kesimlari
- aksiya kursi va ekspertlarning narx prognozi:
- bozor kapitallashuvi haqida ma'lumot:
- aksiyadorlik kapitalining balans qiymati ma'lumotlari:
- qarz majburiyatlari va likvidlik statistikasi:
Umumiy qarzning xususiy kapitalga nisbati Edwards Lifesciences|EW - Uzoq muddatli qarzning kapitalga nisbati|Qisqa muddatli majburiyatlarning kapitalga nisbati edwards.com|EW - Kompaniyaning jamlangan qarzlari|Qarzning balans qiymatiga nisbati Edwards Lifesciences Corp|EW - Kompaniyaning uzoq muddatli qarzlari|Qisqa muddatli qarz hajmi Edwards Lifesciences|Tezkor likvidlik ko‘rsatkichi edwards.com
- sof daromad va qiymat multiplikatorlari ko'rsatkichlari:
EW - Sof foyda|Prognoz qilingan kelajakdagi foyda Edwards Lifesciences|EW - Narxning foydaga nisbati|Kelajakdagi narxning foydaga nisbati Edwards Lifesciences Inc.|EW - Narx-foyda va o‘sish multiplikatori|Biznes qiymatining amortizatsiya chegirilishidan oldingi operatsion foydaga nisbati Edwards Lifesciences Corp|EW - EBITDA operatsion foydasi|So'nggi o'n ikki oy davomida bitta aksiya uchun sof foyda Edwards Lifesciences|EW - So'nggi o'n ikki oy davomida bir aksiya uchun foyda|Sirpanuvchi yil uchun bir aksiya uchun sof foyda o'sishi edwards.com|EW - Bu yil bir aksiya uchun sof foyda o'sishi|Keyingi yil uchun foyda o'sishi prognozi Edwards Lifesciences
Kompaniyaning umumiy tahlili:Edwards (EW)
Edwards Lifesciences kompaniyasining Sapien transkateter klapan segmentidagi ustunligi barqaror pul oqimi va yuqori operatsion samaradorlikni ta'minlaydi. Xarajatlar va biznes kengayish sur'atlari nisbatini tahlil qilib, investor aksiya narxi va foyda o'sishi tezligi o'rtasidagi muvozanatni baholaydi: birdan past qiymatlar aktivning rivojlanish dinamikasiga nisbatan fundamental past baholanganligidan dalolat beradi.
Raqobatdosh kompaniyalar
BSX: Kapitalizatsiyaning foyda va o‘sish sur’atiga nisbati|PEG multiplikatori RMD (ResMed Corp)|Insulet Inc. (PODD) - O‘sish sur’atiga tuzatilgan narx-foyda|Zimmer Biomet Holdings, Inc. - PEG multiplikatori|COO (coopercos.com) - O‘sishni hisobga olgan narx-foyda koeffitsiyenti|ALGN (Align Technology) - Narx-foyda va o‘sish multiplikatori|Globus Medical Inc - O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|Narxning foydaga va o‘sish sur’atiga nisbati TransMedics Group|Narx-foyda va o‘sish multiplikatori Alphatec Corp (ATEC)|PEG multiplikatori AORT|ENOV - O‘sish sur’atiga tuzatilgan narx-foyda|PEG multiplikatori IART (Integra LifeSciences Holdings Corporation)|ESTA: O‘sishni hisobga olgan narx-foyda koeffitsiyenti|Beta Bionics Corp - PEG multiplikatori|O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati IRADIMED Inc. IRMD|EMBC: PEG multiplikatori|Narx-foyda va o‘sish multiplikatori tandemdiabetes.com|AXGN (Axogen) - PEG multiplikatori|PEG multiplikatori SI-BONE Inc|Narxning foydaga va o‘sish sur’atiga nisbati Orthofix International (OFIX)|Narxning foydaga va o‘sish sur’atiga nisbati BVS (Bioventus Global)|OrthoPediatrics - Narx-foyda va o‘sish multiplikatori|O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti TMCI|Strata Critical Medical - PEG multiplikatori|O‘sish sur’atiga tuzatilgan narx-foyda Carlsmed, Inc.|RxSight Corp (RXST) - Narxning foydaga va o‘sish sur’atiga nisbati|Narxning sof foyda o‘sishiga nisbati ClearPoint Neuro CLPT|Narx-foyda va o‘sish multiplikatori STXS|PEG multiplikatori neurostar.com|PEG multiplikatori SGHT|O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati Orchestra BioMed Inc.|Narxning foydaga va o‘sish sur’atiga nisbati Anika Therapeutics, Inc. ANIK|NSPR (InspireMD Inc.) - Kapitalizatsiyaning foyda va o‘sish sur’atiga nisbati|ZJYL - Narxning foydaga va o‘sish sur’atiga nisbati|Vivani Medical, Inc. (VANI) - Narx-foyda va o‘sish multiplikatori|XTNT: PEG multiplikatori|O‘sish sur’atiga tuzatilgan narx-foyda NeuroOne (NMTC)|Narxning foydaga va o‘sish sur’atiga nisbati Modular Medical Inc|O‘sishni hisobga olgan narx-foyda koeffitsiyenti MYO (Myomo Inc)|Narx-foyda va o‘sish multiplikatori COCH (Envoy Medical, Inc.)|Kompaniya qiymatining foyda o‘sish sur’atiga nisbati VVOS|PEG multiplikatori NVNO (enVVeno Medical Corp.)|Sintx Technologies Inc (SINT) - O‘sish sur’atiga tuzatilgan narx-foyda|Tenon Medical, Inc - PEG multiplikatori|LFWD (Lifeward Ltd.) - O‘sishni hisobga olgan narx-foyda koeffitsiyenti|AMIX (autonomix.com) - Narx-foyda va o‘sish multiplikatori|Narx-foyda va o‘sish multiplikatori invobioscience.com|BBLG (Bone Biologics Corp) - PEG multiplikatori|PEG multiplikatori Axonics Inc.|Narxning foydaga va o‘sish sur’atiga nisbati Biolase, Inc. (BIOL)|DYNT (dynatronics.com) - O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|PEG multiplikatori FNA (Paragon 28)|INVO: O‘sishni hisobga olgan narx-foyda koeffitsiyenti
